R
Rodrigo Botero SAS | Medellin, Colombia
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Pembrolizumab
Estrogen
MK-7339
MK-3475-756
Lenvatinib
Olaparib
Docetaxel
Platinum
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
3 of 5 total trials
This study will evaluate the efficacy and safety of olaparib (MK-7339) monotherapy in participants with multiple types of advanced cancer (unresectab...
Enrolling
Advanced Solid Neoplasms
Drug: Olaparib
This is a study of pembrolizumab (MK-3475, KEYTRUDA®) in combination with lenvatinib (E7080) versus treatment of physician's choice (doxorubicin or p...
Active, not recruiting
Endometrial Neoplasms
Drug: Doxorubicin
Drug: Paclitaxel
The purpose of this study is to assess the efficacy and safety of pembrolizumab (MK-3475) versus placebo in combination with neoadjuvant (pre-surgery...
Active, not recruiting
Breast Cancer
Biological: Pembrolizumab (K)
Radiation: Radiation therapy
Trial sponsors
Clinical trials
Research sites
Resources
Legal
© Copyright 2024 Veeva Systems